arrow
N

Nina Worel

medical university vienna
H指数:38
被引数:4,899

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Decentralized CAR-T production: clinical, economic, and regulatory perspectives. Worldwide Network for Blood & Marrow Transplantation (WBMT) special article

去中心化CAR-T生产:临床、经济和监管视角。世界血液与骨髓移植网络(WBMT)专题文章

2026-09-240
PRE
Real-world outcomes of ide-cel and cilta-cel in relapsed/refractory multiple myeloma: A nationwide, retrospective analysis in Austria

ide-cel和cilta-cel在复发/难治性多发性骨髓瘤中的真实世界疗效:奥地利一项全国性回顾性分析

2026-09-060
OAAI
Donor bone marrow together with recipient regulatory T cells induces chimerism without irradiation in kidney transplantation

供者骨髓与受者调节性T细胞联合诱导肾移植中无照射的嵌合体

2026-06-170
PRE
Austrian real-world experience with standard of care brexucabtagene autoleucel in patients with relapsed or refractory mantle-cell lymphoma

奥地利真实世界经验:标准护理条件下brexucabtagene autoleucel在复发或难治性套细胞淋巴瘤患者中的应用

2026-04-170
PRE
Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health Strategy

同种异基因造血细胞与器官移植的相似性与差异,以及我们如何相互借鉴以指导全球健康策略

2025-10-010
OAAI
Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe

呼吁保存CAT在推进欧洲ATMPs方面的专业知识和贡献

2025-09-230
OAAI
Correction: Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation

更正:在资源有限国家中,使用非冷冻保存的自体外周血干细胞移植治疗多发性骨髓瘤和淋巴瘤:来自世界骨髓移植联盟的实践考量

2025-06-300
PRE
CAR-T cell manufacturing failures and out-of-specification products in the real-world setting: A survey from the EBMT cellular therapy and immunobiology working party

CAR-T细胞生产失败和不符合规格的产品在真实世界环境中的情况:EBMT细胞治疗和免疫生物学工作组的一项调查

2025-05-150
PRE
Optimizing CAR-T treatment: A T2EVOLVE guide to raw and starting material selection

优化CAR-T治疗:T2EVOLVE指南——原料和起始物料的选择

2024-11-010
OAAI
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors
2024-05-095
OAAI
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT
2023-12-017
PRE
Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP)
2023-09-060
PRE